Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-062225
Filing Date
2012-11-14
Accepted
2012-11-14 13:30:43
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v326261_10q.htm 10-Q 269927
2 EXHIBIT 31.1 v326261_ex31-1.htm EX-31.1 6633
3 EXHIBIT 31.2 v326261_ex31-2.htm EX-31.2 6560
4 EXHIBIT 32 v326261_ex32.htm EX-32 5722
  Complete submission text file 0001144204-12-062225.txt   2636973

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT phli-20120930.xml EX-101.INS 337982
6 XBRL TAXONOMY EXTENSION SCHEMA phli-20120930.xsd EX-101.SCH 36242
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phli-20120930_cal.xml EX-101.CAL 25143
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phli-20120930_def.xml EX-101.DEF 138644
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE phli-20120930_lab.xml EX-101.LAB 242747
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phli-20120930_pre.xml EX-101.PRE 176097
Mailing Address 100 MATAWAN ROAD SUITE 150 MATAWAN NJ 07747
Business Address 100 MATAWAN ROAD SUITE 150 MATAWAN NJ 07747 732-739-2900
PACIFICHEALTH LABORATORIES INC (Filer) CIK: 0001000278 (see all company filings)

EIN.: 223367588 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 10-Q | Act: 34 | File No.: 000-23495 | Film No.: 121202902
SIC: 2833 Medicinal Chemicals & Botanical Products